Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome

Antiplatelet therapy through inhibition of the adenosine diphosphate (ADP)/P2Y12 pathway is commonly used in the treatment of acute coronary syndrome (ACS). Although efficient in preventing platelet activation and thrombus formation, it increases the risk of bleeding complications. In patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Res Pract Thromb Haemost
Main Authors: Grosdidier, Charlotte, Blanz, Kelly D., Deharo, Pierre, Bernot, Denis, Poggi, Marjorie, Bastelica, Delphine, Wolf, Dennis, Duerschmied, Daniel, Grino, Michel, Cuisset, Thomas, Alessi, Marie‐Christine, Canault, Matthias
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles: Thrombosis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6781928/
https://ncbi.nlm.nih.gov/pubmed/31624788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12244
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados